logo
15:57 Apr 29

Biocon Ltd.

Sector Pharmaceuticals & Biotechnology Industry Biotechnology
Up
318.85
-2.00 (-0.62%)
Sector Pharmaceuticals & Biotechnology Industry Biotechnology

Biocon Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Biotechnology
Up
318.85
-2.00 (-0.62%)
15:57 Apr 29
Quality
image/svg+xml

63/100
High Financial Strength

Valuation
image/svg+xml

41/100
Mid Valuation

Technical

33/100
Technically Bearish

Strength

7

Weakness

8

Opportunity

2

Threats

0

5.16 %

ROE %

1.82 %

ROA %

6.70

EPS

210.51

BVPS

6.92 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM 2024
Net Sales
7105.8 8184 11174.2 14755.7 14761.8
Operating Expenses +
5453.2 6213.8 8662.5 11457 11788.3
Raw Material
2498.6 2975 3817.2 5754.6 5183.3
Increase Decrease in Cost
-290.1 -256.6 -154.1 -856.7 -129.2
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
1741 1880.1 2181 2664.1 3074.9
Miscellaneous Expenses
1640.5 1937.5 4070.6 5260.4 3659.3
Operating Profit
1652.6 1970.2 2511.7 3298.7 2973.5
Other Income
254.5 212.7 375.9 865.5 1250.4
Depreciation
715.1 814.2 1113.1 1568.8 1657.7
Interest
57.7 67.6 419 974.4 912
Profit before tax and exceptio..
1134.3 1301.1 1355.5 1621 1654.2
Exceptional Items
12.6 -111.1 -291.4 -11.6 67.3
PBT
1146.9 1190 1064.1 1609.4 1586.9
Provision for Taxation
221.5 211.5 254.1 227.4 525.9
Net Profit
915.7 978.5 810 1382 1195.6
NET Profit after MI
740.5 648.4 462.7 1022.5 804.3
EPS
6.19 5.42 3.88 8.55 6.72
Operating Profit Margin (%)
23.26 24.07 22.48 22.36 20.14
Net Profit Margin (%)
10.42 7.92 4.14 6.93 5.45

ShareHolding

Promoter

FII

Public

Mutual Funds

Other Institutions

All Data in Percentage (%)

Mar 25 Dec 24 Sep 24 Jun 24 Mar 24
Promoter 60.60 60.60 60.60 60.60 60.60
FII 5.70 5.70 5.90 5.90 5.60
MF 8.80 8.60 8.00 8.70 8.60
Public 17.80 18.10 18.70 18.90 19.70
Others 0.20 0.30 0.30 0.30 0.40
Others 6.90 6.70 6.50 5.60 5.10
Shareholder Shares Holding %
Research 360 logo

Download Our App On: